- Home
- ARGX vs DB Comparison
ARGX vs DB Comparison
Compare ARGX & DB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- DB
- Stock Information
- Founded
- ARGX 2008
- DB 1870
- Country
- ARGX Netherlands
- DB Germany
- Employees
- ARGX N/A
- DB N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- DB Major Banks
- Sector
- ARGX Health Care
- DB Finance
- Exchange
- ARGX Nasdaq
- DB Nasdaq
- Market Cap
- ARGX 40.4B
- DB 33.9B
- IPO Year
- ARGX 2017
- DB N/A
- Fundamental
- Price
- ARGX $644.48
- DB $20.30
- Analyst Decision
- ARGX Strong Buy
- DB Buy
- Analyst Count
- ARGX 20
- DB 2
- Target Price
- ARGX $653.11
- DB N/A
- AVG Volume (30 Days)
- ARGX 225.0K
- DB 2.0M
- Earning Date
- ARGX 02-27-2025
- DB 01-30-2025
- Dividend Yield
- ARGX N/A
- DB 3.50%
- EPS Growth
- ARGX N/A
- DB N/A
- EPS
- ARGX N/A
- DB 1.42
- Revenue
- ARGX $1,908,659,000.00
- DB $29,260,793,052.00
- Revenue This Year
- ARGX $73.18
- DB N/A
- Revenue Next Year
- ARGX $55.26
- DB $2.62
- P/E Ratio
- ARGX N/A
- DB $13.81
- Revenue Growth
- ARGX 85.56
- DB 3.24
- 52 Week Low
- ARGX $349.86
- DB $13.22
- 52 Week High
- ARGX $678.21
- DB $20.96
- Technical
- Relative Strength Index (RSI)
- ARGX 49.33
- DB 60.93
- Support Level
- ARGX $637.15
- DB $20.17
- Resistance Level
- ARGX $652.23
- DB $20.96
- Average True Range (ATR)
- ARGX 12.63
- DB 0.30
- MACD
- ARGX -1.94
- DB 0.02
- Stochastic Oscillator
- ARGX 30.64
- DB 72.50
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About DB Deutsche Bank AG
Deutsche Bank is a universal bank operating on a global scale. The bank offers corporate, retail, investment banking, private banking, and asset management to its clients.